Dermatology NYC Association of Greater New York - (212) - 644 - 9494
Cosmetic Dermatology
Cosmetic DermatologyFractional C02 laser slashes downtime, risks Mar 1, 2008By: John Jesitus Early clinical research shows that fractional deep dermal ablation is safe and effective for severe photodamage including rhytids, skin laxity and pigmentation problems, says a researcher involved with pivotal FDA trials.Fractional photothermolysis improves photodamaged skin Mar 1, 2008By: John Jesitus A nonablative 1,550 nm erbium-doped fiber laser effectively treats facial and non-facial photodamage, rhytids and dyspigmentation with a favorable side effect and recovery profile, according to a recent study.Study highlights longevity of smooth-gel, non-animal hyaluronic acid fillers Mar 1, 2008By: Cheryl Guttman Results from a repeat treatment study highlight the persistence of the benefits provided by the family of smooth-gel hyaluronic acid fillers (Juvéderm, Allergan) for correction of nasolabial folds. The retreatment was administered within 24 to 36 weeks after the last initial treatment. It required significantly less filler volume than originally, and after 24 weeks, was associated with clinically significant improvement exceeding that achieved originally.Q&A: Hair shine and sunscreen safety Mar 1, 2008By: Zoe Diana Draelos, M.D. Zoe Diana Draelos, M.D. answers cosmetic questions about hair shine and sunscreen safetyPeriorbital rejuvenation: 3-D approach addresses underlying structure Mar 1, 2008By: John Jesitus State-of-the-art periorbital rejuvenation requires going beyond skin-tightening surgeries to address underlying structures from a three-dimensional, volumetric standpoint, says an expert.Cosmeceutical regimen: Deliver the results patients crave, but keep it simple Mar 1, 2008By: John Jesitus As the cosmeceuticals category explodes, dermatologists need to know how to dispense practical advice while keeping recommended regimens simple, says an expert.Botulinum toxin in topical form draws interest Mar 1, 2008By: Nancy A. Melville Much about it is still somewhat of a mystery, but early findings on a topical form of botulinum toxin have been compelling enough to earn a $20 million show of support from Medicis and catapult the research onto the cosmetic medicine radar.Rejuvenation: Ablative, nonablative fractional options expanding Mar 1, 2008By: John Jesitus Key developments in facial rejuvenation techniques that promote new collagen induction include the introduction of fractional ablative lasers, as well as the advent of adjunctive treatments including LEDs, fillers and topical agents, an expert says.Biafine noncomedogenic: Emulsion promotes healing by recruiting macrophages Mar 1, 2008By: John Jesitus A relatively new trolamine/sodium alginate emulsion has proven to be noncomedogenic, according to a small study.
Early clinical research shows that fractional deep dermal ablation is safe and effective for severe photodamage including rhytids, skin laxity and pigmentation problems, says a researcher involved with pivotal FDA trials.
A nonablative 1,550 nm erbium-doped fiber laser effectively treats facial and non-facial photodamage, rhytids and dyspigmentation with a favorable side effect and recovery profile, according to a recent study.
Results from a repeat treatment study highlight the persistence of the benefits provided by the family of smooth-gel hyaluronic acid fillers (Juvéderm, Allergan) for correction of nasolabial folds. The retreatment was administered within 24 to 36 weeks after the last initial treatment. It required significantly less filler volume than originally, and after 24 weeks, was associated with clinically significant improvement exceeding that achieved originally.
Zoe Diana Draelos, M.D. answers cosmetic questions about hair shine and sunscreen safety
State-of-the-art periorbital rejuvenation requires going beyond skin-tightening surgeries to address underlying structures from a three-dimensional, volumetric standpoint, says an expert.
As the cosmeceuticals category explodes, dermatologists need to know how to dispense practical advice while keeping recommended regimens simple, says an expert.
Much about it is still somewhat of a mystery, but early findings on a topical form of botulinum toxin have been compelling enough to earn a $20 million show of support from Medicis and catapult the research onto the cosmetic medicine radar.
Key developments in facial rejuvenation techniques that promote new collagen induction include the introduction of fractional ablative lasers, as well as the advent of adjunctive treatments including LEDs, fillers and topical agents, an expert says.
A relatively new trolamine/sodium alginate emulsion has proven to be noncomedogenic, according to a small study.
Enter supporting content here
Dermatology NYC30 East 60th Street Suite 805 New York, NY 10022
Call for appointment: 212.644.9494
